BB Biotech Overview

  • Founded
  • 1993
Founded
  • Status
  • Public
  • Stock Symbol
  • BBZA
Stock Symbol
  • Investments
  • 60
  • Share Price
  • $94.03
  • (As of Friday Closing)

BB Biotech General Information

Description

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the health care system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Capital Markets/Institutions
Stock Exchange
FRA
Primary Office
  • Schwertstrasse 6
  • 8200 Schaffhausen
  • Switzerland
+41 052 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BB Biotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$94.03 $91.47 $53.34 - $94.51 $5.2B 4.47K $12.31

BB Biotech Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 3,372,676 3,628,515
Revenue 731,595 731,595 (433,126) 741,498
Net Income 681,719 681,719 (481,650) 698,285
Total Assets 3,668,549 3,668,549 3,135,316 3,734,561
Total Debt 154,810 154,810 187,905 97,527
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BB Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BB Biotech‘s full profile, request access.

Request a free trial

BB Biotech Executive Team (16)

Name Title Board Seat Contact Info
Rudy Le Blanc Board Member & Managing Director
Claude Mikkelsen Director, Investor Relations
Maria-Grazia Iten-Alderuccio Director, Investor Relations
Felicia Flanigan Executive, Investment Management
Christian Koch Ph.D Executive, Investment Management Team
You’re viewing 5 of 16 executive team members. Get the full list »

BB Biotech Board Members (5)

Name Representing Role Since
00000 00000000 00.0 The Medicines Company Vice Chairman 000 0000
00000 00000000 00.0 Self Chairman & President 000 0000
00000 000000 00.0 Self Member of the Board of Directors 000 0000
0000 00 00000 BB Biotech Board Member & Managing Director 000 0000
To view BB Biotech’s complete board members history, request access »

BB Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BB Biotech‘s full profile, request access.

Request a free trial

BB Biotech Investments & Acquisitions (60)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 01-Feb-2018 00000 00000 00 00000 Drug Discovery
00000 06-Dec-2016 00000 00000 00 0000 Therapeutic Devices
0000000 00000000 27-Oct-2016 000 00000 Biotechnology
00000000 0000 0000 03-Sep-2015 00000 00000 00 000.00 Drug Discovery
Cidara Therapeutics 11-Feb-2015 Early Stage VC 0000 Biotechnology 000 0000000
You’re viewing 5 of 60 investments and acquisitions. Get the full list »

BB Biotech Exits (49)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 01-Feb-2018 00000 00000 00 00000 Completed
  • 13 buyers
00000000 0000 0000 03-Sep-2015 00000 00000 00 000.00 Completed
  • 17 buyers
0000 000000000000 01-Aug-2014 00000 00000 00 00000 Completed
  • 11 buyers
0000 000000000000 11-Mar-2014 00000 00000 00 0000 Completed
  • 6 buyers
Intracellular Therapies 03-Sep-2013 PIPE 0000 Completed
  • 6 buyers
You’re viewing 5 of 49 exits. Get the full list »